From: Relationship between tumor microbiota transcriptional activity and gene expression in breast cancer
ER+/HER2- | ER+/HER2+ | ER-/HER2+ | Triple -negative | P value | |
---|---|---|---|---|---|
subjects (n) | 7 | 48 | 8 | 7 | |
age at surgery (year) | 48.9 ± 10.1 | 54.0 ± 8.4 | 53.9 ± 10.6 | 59.0 ± 11.5 | |
P value | 0.105 * | 0.167 * | 0.386 * | ||
ER status (IHC) | + | + | - | - | |
PR status (IHC) | + | + | - | - | |
HER2 status (IHC) | - | + | + | - | |
lymph node | |||||
Positive (n) | 5 (71%) | 24 (50%) | 5 (63%) | 5 (71%) | 0.497# |
Negative (n) | 2 (29%) | 24 (50%) | 3 (38%) | 2 (29%) | |
Tumor size | 0.943# | ||||
> 20 mm (n) | 3 (43%) | 21 (44%) | 4 (50%) | 4 (57%) | |
≦ 20 mm (n) | 4 (57%) | 27 (56%) | 4 (50%) | 3 (43%) | |
Histological grade | |||||
grade 1 | 0 (0%) | 7 (15%) | 1 (13%) | 1 (14%) | 0.153# |
grade 2 | 4 (57%) | 30 (63%) | 2 (25%) | 3 (43%) | |
grade 3 | 3 (43%) | 11 (23%) | 5 (63%) | 3 (43%) |